UBS O'Connor’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-332,807
Closed -$7.45M 457
2016
Q3
$7.45M Buy
332,807
+297,059
+831% +$5.96M 0.11% 168
2016
Q2
$762K Sell
35,748
-1,711,510
-98% -$32.2M 0.02% 328
2016
Q1
$30.8M Sell
1,747,258
-1,263,220
-42% -$18.8M 0.31% 92
2015
Q4
$45.4M Buy
3,010,478
+1,001,686
+50% +$15.4M 0.4% 56
2015
Q3
$26.4M Buy
2,008,792
+1,908,684
+1,907% +$30.2M 0.25% 103
2015
Q2
$1.88M Sell
100,108
-697,924
-87% -$14.5M 0.02% 434
2015
Q1
$15M Buy
+798,032
New +$13.7M 0.14% 177
2014
Q4
Sell
-94,943
Closed -$3.09M 702
2014
Q3
$3.09M Buy
+94,943
New +$3.22M 0.05% 266

Other funds holding PTEN

UBS O'Connor's PTEN Position: Q4 2016 in Review

UBS O'Connor sold out of Patterson-UTI (PTEN) in Q4 2016, closing a stake of 332,807 shares — an estimated $7.45M sold.

UBS O'Connor first reported a position in PTEN in Q3 2014 and held it in 8 quarters. The position peaked at $45.4M in Q4 2015. 304 funds tracked by Wall St. Rank hold PTEN as of Q4 2016.

  • UBS O'Connor reported no remaining Patterson-UTI position as of Q4 2016 after selling out during the quarter.
  • UBS O'Connor sold 332,807 Patterson-UTI shares in Q4 2016, an estimated $7.45M.
  • UBS O'Connor first reported a position in Patterson-UTI in Q3 2014 and held it in 8 quarters.
  • UBS O'Connor's Patterson-UTI position peaked at $45.4M in Q4 2015.
  • 304 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2016.

Based on UBS O'Connor's 13F filing for Q4 2016, filed 14 Feb 2017.